CNR1 and Parkinson disease: This way, cannabinoids would be interesting new therapeutic agents for the treatment of PD, as they could not only provide neuroprotective effects but also decrease NMDAR-induced excitotoxicity, thanks to the reduction of NMDAR signaling induced by CB1R activation in CB1R-NMDAR complexes.